Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism
in ESRD. To examine the most effective route (intravenous vs.“pulse” oral), dose …

Because intravenous (iv) calcitriol has greater bioavailability than oral calcitriol, it may be
more efficacious in suppressing parathyroid hormone (PTH) secretion. In this study, the …

Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis
patients. Intravenous calcitriol is known to directly suppress PTH secretion and release. We …

Both intermittent intravenous and intermittent oral calcitriol have been shown to be effective
in the treatment of secondary hyperparathyroidism in hemodialysis patients and it has been …

Intermittent bolus administration of calcitriol–ie, 1, 25-dihydroxycholecalcife-rol or 1, 25-(OH)
2D3–is highly efficacious in dialysis patients. In experimental studies, intermittent …

Intermittent calcitriol therapy in secondary hyperparathyroidism: A comparison between oral
and intraperitoneal administration. Background Intermittent oral or intravenous doses of …

Oral pulsed-dose calcitriol administration has been shown to be effective therapy for patients
with secondary hyperparathyroidism. However, this effect is not consistently observed in the …

Secondary hyperparathyroidism is common in dialysis patients. Intravenous calcitriol has
proven to be an effective therapy for the reduction of parathyroid hormone (PTH) levels …

This study evaluates the effect of intravenous calcitriol on parathyroid function and ionized
calcium–PTH sigmoidal curve obtained during lowand high–calcium haemodialysis in 10 …

Oral calcitriol and calcium: An efficient therapy for uremic hyperparathyroidism. Therapy with
orally administered calcitriol often does not adequately control the biochemical …